Drug Profile
Ebeinone
Latest Information Update: 30 May 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antiarrhythmics
- Mechanism of Action Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 03 Sep 1998 No-Development-Reported for Arrhythmias in Pakistan (Unknown route)
- 15 Apr 1996 New profile